Monte Rosa Therapeutics (GLUE) Other Non-Current Assets (2020 - 2026)

Monte Rosa Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $832000.0 for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 82.95% year-over-year to $832000.0; the TTM figure through Mar 2026 stood at $832000.0 (down 82.95% YoY), while the FY2025 annual figure was $148000.0, down 96.96% from the prior year.
• Other Non-Current Assets was $832000.0 for Q1 2026 at Monte Rosa Therapeutics, up from $148000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.3 million in Q1 2022 to a low of $148000.0 in Q4 2025.
• Historically, Other Non-Current Assets has averaged $4.4 million across 5 years, with a median of $4.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets soared 358.16% in 2022, then sank 96.96% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $4.3 million in 2022, then rose by 6.07% to $4.6 million in 2023, then increased by 6.18% to $4.9 million in 2024, then tumbled by 96.96% to $148000.0 in 2025, then surged by 462.16% to $832000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $832000.0 (Q1 2026), $148000.0 (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.